Biotech in a Squeeze: Cuts to Research Are Reshaping the Industry
A change in administration could reverse or mitigate funding in biotech, unleashing pent-up demand for investment. Conversely, if austerity policies become entrenched, biotech may enter a period of constrained growth. Stakeholders must prepare for two divergent scenarios: one where cuts prove temporary, and another where they harden into a new baseline. more....